InsiderTrades

Form 4 for DNA Ginkgo Bioworks Holdings, Inc.

Accepted 2025-01-08 00:00:00 ET · period of report 2025-01-03 · accession 0001127602-25-001025 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-01-08 2025-01-03 DNA Coen Steven P. See remarks M - OptEx — +743 7,456 +11% —
D 2025-01-08 2025-01-06 DNA Coen Steven P. See remarks S - Sale+OE $11.72 -324 7,288 -4% -$3,797
DM 2025-01-08 2025-01-03 DNA Coen Steven P. See remarks M - OptEx — -743 5,939 -11% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2025-01-03 M A 156 — 7,612 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
2 Common Class A Common Stock 2025-01-06 S D 324 $11.72 7,288 D — —
3 Common Class A Common Stock 2025-01-03 M A 587 — 7,456 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
4 Derivative Restricted Stock Units 2025-01-03 M D 587 — 16,449 D — · — to — 587 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F3) The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.
5 Derivative Restricted Stock Units 2025-01-03 M D 156 — 5,939 D — · — to — 156 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F4) The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.